Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies. Candel Therapeutics Inc is a late clinical stage biopharmaceutical company. It is focused on helping patients fight cancer with oncolytic viral immunotherapies.
NEEDHAM, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal...
Announced positive survival data from the phase 2 randomized controlled clinical trial of CAN-2409 in borderline resectable pancreatic cancerPresented positive topline overall survival data from...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.08 | -1.13798008535 | 7.03 | 8.33 | 6.8 | 471695 | 7.47368726 | CS |
4 | 1.12 | 19.2109777015 | 5.83 | 8.33 | 5.77 | 340412 | 6.91881122 | CS |
12 | 0.68 | 10.8452950558 | 6.27 | 8.33 | 4.9 | 302499 | 6.33328586 | CS |
26 | 5.43 | 357.236842105 | 1.52 | 14.33 | 1.45 | 3036073 | 6.79332761 | CS |
52 | 5.81 | 509.649122807 | 1.14 | 14.33 | 0.66 | 1684178 | 6.25321382 | CS |
156 | -2.85 | -29.0816326531 | 9.8 | 14.33 | 0.66 | 582837 | 6.17757902 | CS |
260 | -1.05 | -13.125 | 8 | 14.78 | 0.66 | 562017 | 6.22278931 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.